Skip to content

Inventories at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$14.58B+15.2%
Stryker logo
StrykerSYK
$5.42B+6.2%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$2.25B+0.1%
Medtronic logo
MedtronicMDT
$5.95B+8.7%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$5.83M-4.3%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$177.82M+1.9%

Other financials

Income statement

See full
Revenue$19.9M+14.6%
Gross profit$6.1M+5.8%
Operating income$3.1M-15.0%
Net income$3.9M+20.2%
EPS (diluted)$1.20+22.4%

Balance sheet

See full
Cash & equivalents$10.0M+123%
Total debt$16.0M+43.2%
Total equity$45.2M+28.1%
Total assets$75.0M+16.7%

Cash flow

See full
Operating cash flow$1.6M+488%
CapEx$112.0K-37.8%
Free cash flow$1.5M

Valuation

See full
Market cap$195.81M+39.3%
Enterprise value$201.8M+34.4%
P/E16.3×+0.7×
P/S2.6×+0.5×

Profitability

See full
Gross margin27.8%-3.6pp
Operating margin14.5%-3.8pp
Net margin16.1%+1.5pp
FCF margin-3.8%+3.2pp

Returns & leverage

See full
Return on equity29.8%+1.5pp
Debt / equity0.4×0.0×
Current ratio3.7×+0.9×

Where this comes from

Reported directly by Pro-Dex, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: Pro-Dex, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pro-Dex, Inc.'s inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pro-Dex, Inc.'s inventories?
Pro-Dex, Inc. (PDEX) reported inventories of $22.36M in Q1 2026.
How has Pro-Dex, Inc.'s inventories changed year-over-year?
Pro-Dex, Inc.'s inventories decreased by 4.6% year-over-year, from $23.43M to $22.36M.
What is the long-term trend for Pro-Dex, Inc.'s inventories?
Over 4 years (2021 to 2025), Pro-Dex, Inc.'s inventories has grown at a 27.4% compound annual growth rate (CAGR), from $8.44M to $22.21M.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.